XenaCare announces TV-radio ad campaign for Cobroxin


XenaCare Holdings, a company specializing in the branding, marketing and retail distribution of consumer healthcare products, announced its upcoming Cobroxin advertising campaign to begin on July 28, 2010. The campaign is designed to support the rapidly growing network of retailers carrying Cobroxin, an over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain.

The advertising campaign, which is scheduled to begin on July 28, 2010, and run through December 2010, will consist of 2,515 television commercials in 60, 30 and 10 second spots appearing on major cable stations such as: CNN, Fox News, Food, Travel, ESPN, USA, Lifetime, CNBC, Comedy Central, AMC, History, Discovery, Fox Sports, Headline News (HLN), and Home and Garden. The commercials will also appear on NBC, CBS, and ABC affiliates throughout Boston, Miami, Chicago, Dallas, San Francisco, Pittsburgh, Washington DC, Nashville, Baltimore, Buffalo and New York. Ad placement will include news programs, “Ellen,” “Oprah,” “Dr. Oz,” “David Letterman,” and “Good Morning America.”

In addition to the planned television commercials, the campaign will also include 770 radio spots during drive-time hours in Tampa, Atlanta, New York, Los Angeles and Houston.

“The timing of this campaign is important, as it comes when Cobroxin has full distribution across the United States,” said Frank Rizzo, President of XenaCare. “We originally tested our television commercial on the Hallmark channel last month and in one week, it doubled our sales at several major retailers. With a total household reach of 100 million, we anticipate this campaign will be equally, if not more, successful in pulling Cobroxin sales through the current distribution chain,” he added.

Cobroxin is described as the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. The drug is currently available as an oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.